跳至主要内容
临床试验/IRCT2015050119396N3
IRCT2015050119396N3已完成未知

Estimating the therapeutic effect of 17 alpha-hydroxy progesterone caproate in preventing preterm labor after inhibiting uterine contractions

Hormozgan University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
Female

入选标准

  • Between 26-34 weeks pregnancy age; There premature uterine contractions.
  • Exclusion criteria: the pregnancy age above 34 weeks (since in this group there would be no reason for preventing uterine contractions due to the fetal lung maturation); preterm rupture of membranes; corioamnionite, blood loss prior to the labor due to placental abruption or previa;multiple pregnancies; concomitant systemic diseases (preeclampsia, gestational diabetes (GDM); cardiovascular diseases; kidney diseases; asthma; hyperthyroid; …).

排除标准

  • 未提供

研究者

相似试验